Delivery Order SPE2DB22D2108-SPE2DB25FU5RB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,642.00 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This competitive award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $7,201.78 to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg on July 21, 2025, with completion expected by July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive range of...
- The Defense Logistics Agency awarded a Delivery Order valued at $47,056.22 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 MG tablets (30-count units). This firm fixed-price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive procurement. The pharmaceutical product will be delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a leading pharmaceutical distributor...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,039.16 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the supply of Ondansetron Orally Disintegrating Tablet 8 mg in quantities of 30 tablets. This firm fixed-price delivery order, which is not set-aside, represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,283.84 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count package), with an ultimate completion date of August 13, 2025. This firm fixed price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill...
- The Defense Logistics Agency awarded a $7,527.37 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units) with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded a delivery order valued at $16,416.18 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages) with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $26,821.05 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count packaging), with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $5,153.60 to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the pharmaceutical supply chain support that...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,841.99 by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Ondansetron HCl 4 mg tablets (500 count). This competitively awarded, firm fixed-price delivery order is expected to be completed by July 29, 2025, with performance occurring at the vendor's Conshohocken facility. The contract carries no set-aside designation,...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5RBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,739.64 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion date of September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The order will be fulfilled from the vendor's corporate office location in Conshohocken, PA. This delivery order operates under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and medical devices across multiple therapeutic domains. The company has demonstrated consistent capability in fulfilling federal medical supply requirements through competitive procurement, positioning it as a key provider for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 8/29/25 |